Bloomberg Intelligence cover image

BI Weekend: China Boeing Halt, LVMH Earnings

Bloomberg Intelligence

00:00

Navigating Setbacks: Pfizer and Boeing

This chapter explores Pfizer's decision to halt its obesity drug development due to safety concerns, examining the competitive landscape and potential strategies for growth, including acquisitions. It also analyzes Boeing's challenges in the Chinese market amid trade tensions, assessing the long-term implications for aircraft deliveries and the company's operations. The chapter emphasizes the importance of strategic moves for both Pfizer and Boeing as they adapt to evolving market conditions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app